AI Summary
✦ ClarthaMarico is a branded consumer-products company selling coconut and edible oils, haircare, and packaged food. Parachute and Nihar drive oils, while Saffola anchors functional foods and health products. Recent quarterly revenue and profit beats indicate continued demand, but the stock still fell over 3%, limiting evidence of operating leverage. Revenue grew 26.2% year-on-year, while profit rose only 8.2%, signalling declining margins and weaker earnings conversion. ROE is unavailable; debt/equity of 12.39 implies significant leverage, which can amplify reported ROE but increases financial risk. At 59.2 times earnings, Marico appears rich relative to its profit growth and sector valuation. Positive sentiment and international expansion support the premium, but margin compression and high leverage remain open risks.
Valuation Metrics
Trading 28.6% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.95). Confidence: 84%.
Live forward EPS implies next-12-month EPS of ₹19.52. Applying the stock's normalized valuation corridor produces a fair range of ₹772.02 to ₹974.05, with base value near ₹890.50 (+4.0% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹19.52
Forward P/E
43.8x
Base Fair Value
₹890.50
Fair Range
₹772.02 - ₹974.05
Upside To Base
+4.0%
Estimate Source
Live forward EPS
Growth Estimate
+24.7%
5Y Average
40.87
Current
58.66
Overvalued
49.90
Undervalued
39.55
5Y Average
31.87
Current
45.75
Overvalued
37.40
Undervalued
26.79
5Y Average
5.39
Current
7.73
Overvalued
6.32
Undervalued
4.53
Peers & Comparison
Sector: Consumer Staples · Theme: FMCG - Personal Products
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
P&G HYGIENE & HEALTH CARE PGHHFMCG - Personal Products | -4.9% | 18.6% | 34.7x Undervalued | -51% vs avg | -36.1% |
CUPID LIMITED CUPIDFMCG - Personal Products | +162.5% | 29.5% | 350.2x Premium | +395% vs avg | +692.4% |
DABUR INDIA LTD DABURFMCG - Personal Products | +10.6% | 14.6% | 36.7x Undervalued | -48% vs avg | -17.6% |
GODREJ CONSUMER PRODUCTS GODREJCPFMCG - Personal Products | +15.4% | 12.1% | 56.1x Undervalued | -21% vs avg | -12.5% |
COLGATE PALMOLIVE LTD. COLPALFMCG - Personal Products | +11.8% | 21.7% | 40.5x Undervalued | -43% vs avg | -8.2% |
LIFE INSURA CORP OF INDIA LICIFMCG - Personal Products | +6.8% | 6.5% | 8.6x Undervalued | -88% vs avg | -14.2% |
PATANJALI FOODS LIMITED PATANJALIPackaged Foods & Meats | +14.7% | 4.5% | 21.3x Undervalued | -70% vs avg | -41.5% |
ITC LTD ITCFMCG - Tobacco | -11.1% | 25.9% | 17.8x Undervalued | -75% vs avg | -32.1% |
MARICO LIMITED trades at a discount (58.7x vs peer avg 70.7x), suggesting potential undervaluation relative to the Fmcg - Personal Products cohort. Peers include P&G HYGIENE & HEALTH CARE, CUPID LIMITED, DABUR INDIA LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹2.79K CrJun 2026Latest net profit
₹460 CrJun 2026Latest EPS
₹3.54Jun 2026Net margin
19.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,841 | 1,791 | 1,733 | 1,637 | 1,886 | 1,860 | 1,988 | 1,870 | 2,349 | 2,439 | 2,461 | 2,272 | 2,794 |
| Expenses + | 1,438 | 1,449 | 1,369 | 1,340 | 1,458 | 1,515 | 1,630 | 1,558 | 1,902 | 2,092 | 2,089 | 1,978 | 2,251 |
| Operating Profit | 403 | 342 | 364 | 297 | 428 | 345 | 358 | 312 | 447 | 347 | 372 | 294 | 543 |
| OPM % | 22% | 19% | 21% | 18% | 23% | 19% | 18% | 17% | 19% | 14% | 15% | 13% | 19% |
| Other Income + | 37 | 35 | 35 | 28 | 18 | 302 | 122 | 149 | 473 | 171 | 177 | 166 | 53 |
| Interest | 7 | 10 | 8 | 7 | 5 | 7 | 6 | 5 | 6 | 7 | 7 | 8 | 10 |
| Depreciation | 25 | 26 | 29 | 27 | 28 | 28 | 30 | 38 | 31 | 33 | 34 | 45 | 37 |
| Profit before tax | 408 | 341 | 362 | 291 | 413 | 612 | 444 | 418 | 883 | 478 | 508 | 407 | 549 |
| Tax % | 25% | 24% | 22% | 21% | 25% | 14% | 17% | 22% | 12% | 17% | 13% | 15% | 16% |
| Net Profit + | 307 | 258 | 284 | 229 | 311 | 529 | 369 | 325 | 773 | 395 | 441 | 344 | 460 |
| EPS in Rs | 2.37 | 1.99 | 2.19 | 1.77 | 2.40 | 4.09 | 2.85 | 2.51 | 5.96 | 3.04 | 3.40 | 2.65 | 3.54 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS